載入...
ERYTHROPOIETIN: ELUCIDATING NEW CELLULAR TARGETS THAT BROADEN THERAPEUTIC STRATEGIES
Given that erythropoietin (EPO) is no longer believed to have exclusive biological activity in the hematopoietic system, EPO is now considered to have applicability in a variety of nervous system disorders that can overlap with vascular disease, metabolic impairments, and immune system function. As...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2441910/ https://ncbi.nlm.nih.gov/pubmed/18396368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pneurobio.2008.02.002 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|